Dyslipidaemia in Type 1 Diabetes: Molecular Mechanisms and Therapeutic Opportunities

Dyslipidaemia in Type 1 Diabetes: Molecular Mechanisms and Therapeutic Opportunities

Cardiovascular disease (CVD) is the leading cause of death in Type 1 Diabetes (T1D). The molecular basis for atherosclerosis in T1D is heavily influenced by hyperglycaemia and its atherogenic effects on LDL. Ongoing research into the distinct pathophysiology of atherosclerosis in T1D offers exciting...

Full description

Bibliographic Details
Main Authors: Stephen T. O’Brien, Orla M. Neylon, Timothy O’Brien
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Biomedicines
Subjects:
Type 1 diabetes mellitus
dyslipid(a)emia
atherosclerosis
Online Access:https://www.mdpi.com/2227-9059/9/7/826

Similar Items

Similar Items